RAYMOND JAMES & ASSOCIATES - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,200
-29.8%
14,0000.0%0.00%
Q2 2023$15,960
-24.0%
14,0000.0%0.00%
Q1 2023$21,000
-25.8%
14,000
-26.3%
0.00%
Q4 2022$28,310
-2.4%
19,0000.0%0.00%
Q3 2022$29,000
-32.6%
19,0000.0%0.00%
Q2 2022$43,000
+43.3%
19,000
+46.2%
0.00%
Q1 2022$30,00013,0000.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders